The latest closing stock price for Kalaris Therapeutics as of May 16, 2025 is 3.48.
An investor who bought $1,000 worth of Kalaris Therapeutics stock at the IPO in 2020 would have $-994 today, roughly -1 times their original investment - a -64.10% compound annual growth rate over 5 years.
The all-time high Kalaris Therapeutics stock closing price was 1076.63 on December 04, 2020.
The Kalaris Therapeutics 52-week high stock price is 24.14, which is 593.7% above the current share price.
The Kalaris Therapeutics 52-week low stock price is 3.10, which is 10.9% below the current share price.
The average Kalaris Therapeutics stock price for the last 52 weeks is 13.50.
An investor who bought $1,000 worth of Kalaris Therapeutics stock at the IPO in 2020 would have $-994 today, roughly -1 times their original investment - a -64.10% compound annual growth rate over 5 years.
The all-time high Kalaris Therapeutics stock closing price was 1076.63 on December 04, 2020.
The Kalaris Therapeutics 52-week high stock price is 24.14, which is 593.7% above the current share price.
The Kalaris Therapeutics 52-week low stock price is 3.10, which is 10.9% below the current share price.
The average Kalaris Therapeutics stock price for the last 52 weeks is 13.50.